2013
Hauber I, Hofmann-Sieber H, Chemnitz J, Dubrau D, Chusainow J, Stucka R, Hartjen P, Schambach A, Ziegler P, Hackmann K, Schröck E, Schumacher U, Lindner C, Grundhoff A, Baum C, Manz MG, Buchholz F, Hauber J (2013). Highly significant antiviral activity of HIV-1 LTR-specific tre-recombinase in humanized mice. PLoS Pathogens. Sep;9(9):e1003587. PubMed
Scheibe M, Arnoult N, Kappei D, Buchholz F, Decottignies A, Butter F, Mann M (2013). Quantitative interaction screen of telomeric repeat-containing RNA reveals novel TERRA regulators. Genome Res. Dec;23(12):2149-57. PubMed
Hirst J, Borner GH, Edgar J, Hein MY, Mann M, Buchholz F, Antrobus R, Robinson MS (2013). Interaction Between AP-5 and the Hereditary Spastic Paraplegia Proteins SPG11 and SPG15. Mol Biol Cell. Aug;24(16):2558-69. PubMed
Kappei D, Butter F, Scheibe M, Draskovic I, Krastev DB, Kittler R, Londono-Vallejo JA, Mann M, Buchholz F (2013). Hot1, a novel direct telomere-repeat binding protein, controls telomere length through interaction with active telomerase. EMBO J. Jun 12;32(12):1681-701. PubMed
Niebuhr B, Kriebitzsch N, Fischer M, Behrens K, Günther T, Alawi M, Bergholz U, Müller U, Roscher S, Ziegler M, Buchholz F, Grundhoff A, Stocking C (2013). Runx1 is essential at two stages of early murine B-cell development. Blood, Jul 18;122(3):413-23. PubMed
Caldarelli A, Müller JP, Paskowski-Rogacz M, Herrmann K, Bauer R, Koch S, Henninger AK, Krastev D, Ding L, Kasper S, Fischer T, Brodhun M, Böhmer FD, Buchholz F (2013). A genome-wide RNAi screen identifies proteins modulating aberrant FLT3-ITD signaling. Leukemia, Mar 19. doi: 10.1038/leu.2013.83. PubMed
Thieme S, Gyárfás T, Richter C, Ozhan G, Fu J, Alexopulou D, Muders MH, Michalk I, Jakob C, Dahl A, Klink B, Bandola J, Bachmann M, Schröck E, Buchholz F, Stewart AF, Weidinger G, Anastassiadis K, Brenner S (2013). The histone demethylase UTX regulates stem cell migration and hematopoiesis. Blood, Mar 28;121(13):2462-73. PubMed
Karimova M, Abi-Ghanem J, Berger N, Surendranath V, Pisabarro MT, Buchholz F (2013). Vika/vox, a novel efficient and specific Cre/IoxP-like site-specific recombination system. Nucleic Acids Res. 41(2):e37. PubMed
Abi-Ghanem J, Chusainow J, Karimova M, Spiegel C, Hofmann-Sieber H, Hauber J, Buchholz F, Pisabarro MT (2013). Engineering of a target site-specific recombinase by a combined evolution- and structure-guided approach. Nucleic Acids Res. Feb 1;41(4):2394-403. PubMed
Buchholz F, Hauber J (2013). Engineered DNA modifying enzymes: Components of a future strategy to cure HIV/AIDS. Antiviral Res. Feb;97(2):211-7. PubMed
Surendranath V, Theis M, Habermann BH, Buchholz F (2013). Designing efficient and specific endoribonuclease-prepared siRNAs. Methods Mol Biol. 2013;942:193-204. PubMed
Hauber J, Hauber I, Buchholz F (2013). Revolutionizing HIV-therapy by Tre-Recombinase? Initial observations and current state of development. MW Fortschr Med. Jun 13;155 Suppl 1:22-3. PubMed